PMID- 3051159
OWN - NLM
STAT- MEDLINE
DCOM- 19881107
LR  - 20220330
IS  - 0889-857X (Print)
IS  - 0889-857X (Linking)
VI  - 14
IP  - 2
DP  - 1988 Aug
TI  - Therapy in gout.
PG  - 441-57
AB  - The effective management of patients with gout is outlined. The treatment of the 
      acute attack, the prevention of recurrent episodes, and the dissolution of tophi, 
      when present, are generally straightforward and associated with relatively few 
      complications. Patients with a resistant acute attack, with extensive tophaceous 
      deposition, or with allergy or toxicity to any of the standard drugs, present 
      more complex treatment decisions. All agents must be used in an individualized 
      manner for each patient with appropriate concern for risks as well as for 
      benefit.
FAU - Wallace, S L
AU  - Wallace SL
AD  - Department of Medicine, State University of New York Health Sciences Center, 
      Brooklyn.
FAU - Singer, J Z
AU  - Singer JZ
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Rheum Dis Clin North Am
JT  - Rheumatic diseases clinics of North America
JID - 8708093
RN  - 0 (Anti-Inflammatory Agents, Non-Steroidal)
RN  - 268B43MJ25 (Uric Acid)
RN  - SML2Y3J35T (Colchicine)
SB  - IM
MH  - Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
MH  - Calculi/drug therapy/prevention & control
MH  - Colchicine/therapeutic use
MH  - Gout/*drug therapy/prevention & control
MH  - Humans
MH  - Recurrence
MH  - Uric Acid/blood
RF  - 82
EDAT- 1988/08/01 00:00
MHDA- 1988/08/01 00:01
CRDT- 1988/08/01 00:00
PHST- 1988/08/01 00:00 [pubmed]
PHST- 1988/08/01 00:01 [medline]
PHST- 1988/08/01 00:00 [entrez]
PST - ppublish
SO  - Rheum Dis Clin North Am. 1988 Aug;14(2):441-57.